|View printer-friendly version|
|INC Research Discusses Benefits of Involving CROs Early in Planning at Partnerships in Clinical Trials 2012|
Global CRO Offers Ways to Accelerate Pipeline Success through Innovation, Early Involvement
Camberley, UK, Nov. 5, 2012 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the importance of involving CROs early in the planning process at the Partnerships in Clinical Trials conference, November 6-9, 2012 at the CCH Congress Center in Hamburg, Germany. Visit Booth #709 where INC Research executives will be on site to discuss how drug developers can identify the right strategic alliance model to meet their outsourcing needs and ensure the best chance of success in bringing their products to market.
"We're excited to be taking part again in this year's Partnerships in Clinical Trials," said Alistair Macdonald, President, Clinical Development Services, and head of the Company's European operations. "Europe continues to be an important region for clinical research, particularly in the areas of oncology, CNS, cardiology, and endocrinology, which are currently experiencing significant growth in the region. By having locally-based teams with strong regional knowledge of every European country, we can engage our customers earlier in the product lifecycle to offer more insightful strategies that ultimately speed their products to market. And if customers are looking beyond Europe, our global footprint also enables us to deliver high-quality clinical development service anywhere in the world."
The continued shift in the biopharmaceutical company-CRO relationship from project-specific outsourcing to clinical delivery strategic alliances has made it easier for drug developers to benefit from CROs as innovation partners. Multi-year strategic alliances include more input from the CRO and leverage years of perspective, expertise and tactical approaches. These strategic alliances enable CROs to focus more deeply on the commercial and regulatory viability of compounds much earlier in the drug development lifecycle.
INC Research Speaker
Additionally, INC Research executives will be on hand to discuss recent developments in:
With global experience in more than 100 countries and the extensive therapeutic expertise to work in nearly any indication, INC Research is a leader in developing innovative and flexible strategic alliances that enable customers to quickly and efficiently assess product potential. From full-service strategic partnerships to functional service provider (FSP) alliances, networked drug development to niche solutions tailored to individual customer needs, INC Research can advise customers on the development model that best fits their unique requirements. INC Research has a strong track record in Europe where the Company has run trials in every European country, including those in Central and Eastern Europe.
For more information about INC Research's capabilities for conducting clinical trials in Europe, please visit booth #709 at Partnerships in Clinical Trials or download our European capabilities brochure. Customers interested in contacting INC Research can reach us in Europe at +44 1276 4810000 or at email@example.com.
About INC Research
Contact: Lori Dorer, Media +1 (513) 345-1685